News
HHS To Require Placebo-Controlled Trials for All New Vaccines in ‘Radical Departure’ From Past
The new policy, revealed by the Department of Health and Human Services on Wednesday, would make vaccines “less available and less affordable,” according to vaccine expert Paul Offit. It could also further complicate the picture for companies like Novavax.
The US Department of Health and Human Services said Thursday that it aims to accomplish within four years a scientific feat ...
HHS implemented a pause on research of deadly infectious diseases at one of the nation's most highly secure research labs, ...
The Department of Health and Human Services said it is redirecting funding from what it calls a wasteful Biden-era project on ...
In February, the HHS unexpectedly delivered notice that the South San Francisco-based company was to stop all work on the ...
While Vaxart can proceed with its study, fellow COVID-19 vaccine developers GeoVax and Novavax continue to be hamstrung by ...
On a Thursday conference call with investors, Moderna CFO Jamey Mock outlined a roadmap for the mRNA specialist to lower its ...
The director of national intelligence told podcast host Megyn Kelly she's working with top HHS officials to investigate Covid-19's origins.
Confusion over the FDA delay in granting full approval to Novavax’s Covid-19 vaccine deepened over the weekend, with possible ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback